North Carolina has nurtured and invested in its life sciences sector since the dawn of biotechnology four decades ago, resulting in its position today as a global life sciences leader. Biomanufacturing, gene and cell therapy, regenerative medicine and clinical services are among the state’s core strengths.
Despite challenges associated with the COVID-19 pandemic, North Carolina’s life sciences sector has grown steadily. Across the state, there are 810+ life sciences companies, including leaders such as Amgen, Baxter, Biogen, CSL Seqirus, Eli Lilly and Company, FUJIFILM Diosynth Biotechnologies, GSK, ICON, IQVIA, Labcorp, Merck, Novo Nordisk, Parexel, Pfizer, Syneos Health and Thermo Fisher Scientific.
The 2022 TEConomy Report says North Carolina’s growth has outpaced most U.S. life sciences hubs. Fierce Biotech says our Research Triangle region is the nation’s fourth-leading hub for biotech activity.
North Carolina’s life sciences workforce is 75,000 employees strong and growing steadily. The state’s continuum of training programs and long-standing public-private partnerships have been key to meeting life sciences companies’ needs.
Scientific innovations from our renowned research universities are steadily advancing technologies and seeding spinouts. The state’s scientific infrastructure includes five medical schools, four pharmacy schools and three comprehensive cancer centers. North Carolina-based organizations received $2.4 billion in NIH awards in FY2021, ranking our state consistently among the nation’s top research hubs.
North Carolina has long been recognized as a business-friendly state because of its low taxes, low business costs, and favorable legal and regulatory environment. In 2022, it was heralded as:
• Top state for business by CNBC
• Best business climate by Site Selection magazine
• State of the Year by Business Facilities magazine.
In 2025, the corporate income tax rate will drop to 2.25% and continue to decrease to 0% in 2030. Business operating costs in North Carolina are lower than in almost every leading U.S. life sciences hub.
At the heart of the state’s life sciences leadership is the North Carolina Biotechnology Center, a private, state-funded nonprofit. NCBiotech provides resources and connections that help life sciences entrepreneurs and companies thrive in North Carolina.
NCBiotech supports the progression of ideas from research lab to marketplace by investing in technology development through academic grants and in company development through loans. NCBiotech is headquartered in the Research Triangle Park, with regional offices in Asheville, Charlotte, Greenville, Wilmington and Winston-Salem.
Visit booth #235 and engage with NCBiotech and our partners: Biogen, the BioPharma Crescent, the Catalyst BioCampus, the Charlotte Regional Business Alliance/Select CLT, the Economic Development Partnership of North Carolina, FUJIFILM Diosynth Biotechnologies, Hub RTP, UNC Innovation Carolina, and Wake County Economic Development.
Despite challenges associated with the COVID-19 pandemic, North Carolina’s life sciences sector has grown steadily. Across the state, there are 810+ life sciences companies, including leaders such as Amgen, Baxter, Biogen, CSL Seqirus, Eli Lilly and Company, FUJIFILM Diosynth Biotechnologies, GSK, ICON, IQVIA, Labcorp, Merck, Novo Nordisk, Parexel, Pfizer, Syneos Health and Thermo Fisher Scientific.
The 2022 TEConomy Report says North Carolina’s growth has outpaced most U.S. life sciences hubs. Fierce Biotech says our Research Triangle region is the nation’s fourth-leading hub for biotech activity.
North Carolina’s life sciences workforce is 75,000 employees strong and growing steadily. The state’s continuum of training programs and long-standing public-private partnerships have been key to meeting life sciences companies’ needs.
Scientific innovations from our renowned research universities are steadily advancing technologies and seeding spinouts. The state’s scientific infrastructure includes five medical schools, four pharmacy schools and three comprehensive cancer centers. North Carolina-based organizations received $2.4 billion in NIH awards in FY2021, ranking our state consistently among the nation’s top research hubs.
North Carolina has long been recognized as a business-friendly state because of its low taxes, low business costs, and favorable legal and regulatory environment. In 2022, it was heralded as:
• Top state for business by CNBC
• Best business climate by Site Selection magazine
• State of the Year by Business Facilities magazine.
In 2025, the corporate income tax rate will drop to 2.25% and continue to decrease to 0% in 2030. Business operating costs in North Carolina are lower than in almost every leading U.S. life sciences hub.
At the heart of the state’s life sciences leadership is the North Carolina Biotechnology Center, a private, state-funded nonprofit. NCBiotech provides resources and connections that help life sciences entrepreneurs and companies thrive in North Carolina.
NCBiotech supports the progression of ideas from research lab to marketplace by investing in technology development through academic grants and in company development through loans. NCBiotech is headquartered in the Research Triangle Park, with regional offices in Asheville, Charlotte, Greenville, Wilmington and Winston-Salem.
Visit booth #235 and engage with NCBiotech and our partners: Biogen, the BioPharma Crescent, the Catalyst BioCampus, the Charlotte Regional Business Alliance/Select CLT, the Economic Development Partnership of North Carolina, FUJIFILM Diosynth Biotechnologies, Hub RTP, UNC Innovation Carolina, and Wake County Economic Development.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
